ESR-Reit - Stock calls

Date	Analyst	Company	Last	Target	Call	Valuation
07/17/20	CIMB	ESR-Reit	0.39	0.492	Add	DDM
07/17/20	Lim & Tan	ESR-Reit	0.39	0	Accept Offer
07/17/20	CLSA	ESR-Reit	0.39	0.47	Buy
07/17/20	Soochow	ESR-Reit	0.39	0.47	Buy
07/17/20	Morningstar	ESR-Reit	0.39	0.42	Stable
07/17/20	Daiwa	ESR-Reit	0.39	0.42	Hold
08/24/20	OCBC	ESR-Reit	0.385	0.45	Buy
10/16/20	OCBC	ESR-Reit	0.385	0.45	Buy
11/02/20	phillip	ESR-Reit	0.35	0	Neutral
11/02/20	DBS Vickers	ESR-Reit	0.35	0.43	Buy	DCF
11/04/20	CIMB	ESR-Reit	0.36	0.49	Add
11/20/20	CIMB	ESR-Reit	0.39	0.494	Add
01/21/21	DBS Vickers	ESR-Reit	0.41	0.45	Buy	DCF
01/21/21	DMG & Partners	ESR-Reit	0.41	0.48	Buy
01/21/21	OCBC	ESR-Reit	0.41	0.47	Buy
01/25/21	CIMB	ESR-Reit	0.405	0.49	Add
02/23/21	DBS Vickers	ESR-Reit	0.385	0.45	Buy

Ellipsiz - Stock calls

Date	Analyst	Company	Last	Target	Call	Valuation
08/28/20	Lim & Tan	Ellipsiz	0.33	0	Hold

Elite ComReit - Stock calls

Date	Analyst	Company	Last	Target	Call	Valuation
05/26/20	UOB Kay Hian	Elite ComReit	0.66	0.88	Buy	DDM
06/30/20	CIMB	Elite ComReit	0.7	1.3	Add
07/24/20	CIMB	Elite ComReit	0.695	0.761	Add	DDM
07/27/20	UOB Kay Hian	Elite ComReit	0.695	0.88	Buy	DDM
10/20/20	CIMB	Elite ComReit	0.65	0.781	Add
11/12/20	UOB Kay Hian	Elite ComReit	0.635	0.88	Buy	DDM
02/03/21	CIMB	Elite ComReit	0.67	0.79	Add	DDM
03/12/21	UOB Kay Hian	Elite ComReit	0.655	0.95	Buy	DDM

Stock calls for 25 March 2021

Date	Analyst	Company	Last	Target	Call	Valuation
03/25/21	Phillip	Capitaland	3.71	4.38	Buy	Sum of parts
03/25/21	Lim & Tan	Keppel Corp	5.22	0	Buy
03/25/21	UOB Kay Hian	Keppel Reit	1.2	1.49	Buy	DDM

AstraZeneca doesn't take into account asymptomatic patients in its efficacy rate.

https://www.cnbc.com/2021/03/24/covid-vaccine-astrazeneca-issues-updated-phase-3-trial-data.html

The western vaccines such as Pfizer, Moderna and Astrazeneca don't take into account asymptomatic patients in their efficacy rates and also don't focus on a high-risk group such as medical staff.

Let me highlight 2 things here.

If you didn't have any symptoms but were tested positive for covid infection, the vaccine was considered effective in the clinical trial.  Furthermore, the clinical trial patients were the general public whereby most of them were not exposed to the covid virus on a daily basis.  Therefore, we couldn't determine whether the vaccine was really effective or the patients were simply not exposed to the virus and gave a false sense that the vaccine was effective.

These conditions were completely different from China vaccine clinical trial whereby asymptomatic patients were taken into account and the trial focused on a high-risk group (medical workers) who were exposed to the covid virus on a daily basis.

The western pharmaceutical companies used laxly standards to boost up their efficacy rates so that they could sell their drugs.

In conclusion, we could see a resurgence in covid cases despite the higher vaccination rates which we're seeing right now.  In fact, some EU countries are going into lockdowns again despite more Europeans getting vaccinated.

https://abcnews.go.com/Health/wireStory/germany-set-extend-lockdown-measures-76600707

EC World Reit - Stock calls

Date	Analyst	Company	Last	Target	Call	Valuation
05/14/20	DMG & Partners	EC World Reit	0.675	0.76	Buy	DDM
05/14/20	DBS Vickers	EC World Reit	0.675	0.8	Buy	DCF
05/15/20	phillip	EC World Reit	0.66	0.77	Buy	DDM
05/18/20	Amfrasers	EC World Reit	0.675	0.73	outperform	DDM
06/23/20	DMG & Partners	EC World Reit	0.7	0.76	Buy
07/13/20	Amfrasers	EC World Reit	0.655	0.73	outperform	DDM
08/12/20	Amfrasers	EC World Reit	0.655	0.73	outperform	DDM
08/12/20	DMG & Partners	EC World Reit	0.655	0.76	Buy	DDM
10/12/20	Amfrasers	EC World Reit	0.675	0.73	outperform
11/12/20	Amfrasers	EC World Reit	0.695	0.74	outperform
02/25/21	DBS Vickers	EC World Reit	0.72	0.8	Buy	DCF
03/05/21	DMG & Partners	EC World Reit	0.73	0.76	Neutral

Delfi - Stock calls

Date	Analyst	Company	Last	Target	Call	Valuation
05/22/20	DBS Vickers	Delfi	0.83	1.08	Buy	PER18x FY20/21
06/05/20	Amfrasers	Delfi	0.77	0.93	outperform
07/15/20	DMG & Partners	Delfi	0.74	0.74	Neutral	DCF
08/13/20	DMG & Partners	Delfi	0.74	0.8	Neutral	DCF
08/14/20	DBS Vickers	Delfi	0.725	0.98	Buy	PER18x FY21
08/20/20	Amfrasers	Delfi	0.74	0.93	outperform	PER15x
11/20/20	Lim & Tan	Delfi	0.66	0	Accumulate
01/06/21	DBS Vickers	Delfi	0.71	0.98	Buy
02/26/21	DBS Vickers	Delfi	0.76	0.96	Buy	PER18x FY21
03/11/21	Lim & Tan	Delfi	0.755	0	Accumulate